expansion cohort results of ragnar: erdafitinib in cca with fgfr alterations
Published 1 year ago • 51 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
2:33
ragnar study evidences efficacy and safety of erdafitinib in patients with advanced fgfr malign...
-
3:09
overall survival results from monaleesa-3 study on ribociclib plus fulvestrant in advanced breas...
-
2:01
qol analyses from rationale-301 of tislelizumab vs sorafenib in hcc
-
1:21
preimplantation genetic diagnosis
-
2:01
fgfr mutations
-
2:27
pan-fgrf inhibitors in different fgfr alteration types across solid tumours
-
19:50
3mensio ct pre-case planning: redo-tavr with prior evolut pro
-
7:44
肝膽相照論胃腸-肝內膽管癌精準降臨 fgfr標靶治療
-
3:36
outcomes of patients with newly diagnosed crlf2-rearranged b-all
-
1:16
quick treatment leads to better results & lower cost
-
23:19
cesnjevar: "timing for reoperation on the right side"
-
2:40
the rapid growth of fgfr2 inhibitors: pemigatinib in fight-202
-
1:57
phase i results of a novel fgfr inhibitor
-
2:40
rayone implantation - prof. oliver findl, hanusch hospital vienna
-
4:03
fgfr inhibitors for cca & bladder cancer
-
6:29
fibroblast growth factor
-
13:26
how long do regenerative treatments last?
-
1:59
monarche: patient-reported outcomes
-
2:01
evaluation: keratinocyte proliferation on 2d & 3d type i collagen substrates l protocol preview
-
0:29
juan ortega - vantage orian 1.5t encore upgrade
-
12:33
3mensio ct pre-case planning: valve-in-valve tavr in epic/biocor